Advertisement

Dipyridamole Injection

[06 August 2014]

Products Affected - Description

Dipyridamole 5 mg/mL injection, Teva
2 mL vial, 25 count (NDC 00703-1652-04)
10 mL vial, 10 count (NDC 00703-1654-03)
 
Dipyridamole 5 mg/mL injection, West-Ward (formerly Baxter)
10 mL vial (NDC 00641-2569-44)

Reason for the Shortage

  • Bedford discontinued dipyridamole injection in May, 2011 to concentrate on the manufacturing of other products.
  • Teva has temporarily discontinued their 2 mL and 10 mL products in order to increase the package sizes.

Available Products

Insufficient supplies for usual ordering.

Estimated Resupply Dates

  • Teva has temporarily discontinued dipyridamole 5 mg/mL 2 mL and 10 mL vials. The company cannot estimate a release date for the new presentations.
  • West-Ward has dipyridamole 5 mg/mL 10 mL vials available with an expiration date of July 2015.

Related Shortages

Updated

August 6, 2014; April 14, 2014; January 8, 2014; October 4, 2013; August 1, 2013; June 4, 2013; March 14, 2013; January 14, 2013; December 21, 2012; December 10, 2012; December 5, 2012; November 16, 2012; November 5, 2012; October 12, 2012; October 4, 2012; August 22, 2012; July 25, 2012; May 18, 2012; March 6, 2012; January 18, 2012; December 6, 2011; October 5, 2011; August 3, 2011; June 9, 2011; May 4, 2011; March 29, 2011; February 16, 2011; December 17, 2010; November 12, 2010; October 11, 2010; September 1, 2010; August 2, 2010; June 30, 2010; June 9, 2010; April 20, 2009; March 9, 2009; January 27, 2009; November 25, 2008; October 20, 2008; September 3, 2008, Drug Information Service, University of Utah, Salt Lake City, UT. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement